Orteronel fails to improve overall survival in metastatic prostate cancer: Study Dr. Hiral patel10 July 2022 8:00 PM ISTUSA: For patients with newly diagnosed metastatic hormone-sensitive prostate cancer, the addition of orteronel to androgen deprivation therapy (ADT)...
Additional taxane maintenance therapy fails to improve survival for women with advanced cancers Dr. Kamal Kant Kohli30 Jun 2022 9:30 AM ISTResults from the NRG Oncology phase III clinical trial NRG GOG-0212 indicated that treating women who received complete clinical response (CCR) after...
Enzalutamide effective in patients with metastatic Hormone-Sensitive Prostate Cancer Dr. Shravani Dali16 Jun 2022 8:00 PM ISTEnzalutamide therapy is beneficial in patients with Metastatic Hormone-Sensitive Prostate Cancer, according to a recent study published in the...
Trimodal Therapy a Potential Alternative to Radical Cystectomy MD Bureau30 April 2022 9:00 AM ISTRadical cystectomy (RC) has long been the standard of care for the management of muscle-invasive bladder cancer (MIBC). However, an increasing trend...
Prophylactic Compression Sleeves reduces Breast Cancer-Related Lymphedema; ASCO Medical Dialogues Editorial Team11 March 2022 9:00 AM ISTIn women at high risk for lymphedema, prophylactic usage of compression sleeves reduced and delayed the emergence of arm swelling in the first year...
Breast cancer survivors at increased risk of diabetes and hypertension: ASCO Medical Dialogues Editorial Team5 March 2022 9:00 AM ISTUSA: In a new study conducted by Marilyn L. Kwan and team, it was found that breast cancer (BC) survivors at Kaiser Permanente Northern California...
Bupropion of no significant benefit for enhancing sexual desire in cancer survivors: Study Medical Dialogues Editorial Team18 Jan 2022 9:15 AM ISTUSA: Bupropion was not more beneficial than placebo in enhancing the Female Sexual Function Index (FSFI) desired subscale, according to a recent study...
Immunotherapy drug shows promise in advanced endometrial cancer Hina Zahid10 Jan 2022 9:00 AM ISTCOLUMBUS, Ohio - A cancer immunotherapy drug currently approved by the U.S. Food and Drug Administration (FDA) to treat several forms of cancer is...
Abiraterone acetate helps with better quality of life than Docetaxel in Prostate Cancer: ASCO Medical Dialogues Editorial Team4 Jan 2022 9:00 AM ISTIn a new research done by Hannah L Rush and colleagues, it was shown that during a 2-year period, patient-reported QOL was superior for patients...
Nivolumab and Ipilimumab combo bests monotherapy in improving clinical outcomes in Advanced Melanoma MD Editorial Team17 Dec 2021 9:00 AM ISTIn a new study CheckMate 067, the results demonstrated durable, improved clinical outcomes with nivolumab plus ipilimumab or nivolumab versus...
ASCO guideline on prevention and management of chemotherapy-induced PN in cancer survivors Medha Baranwal23 Nov 2021 7:00 PM ISTUSA: The American Society of Clinical Oncology (ASCO) has released an updated guideline on the prevention and management of chemotherapy-induced...
Prevention of Xerostomia and salivary gland hypofunction induced by nonsurgical cancer therapies: Updated guidelines Medha Baranwal24 Aug 2021 9:00 AM ISTUSA: Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and ASCO have released a new guideline...
